The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Institutional experience with nab-sirolimus in patients with malignancies harboring TSC1 or TSC2 mutations.

Mark Andrew  Dickson

Consulting or Advisory Role - Celgene

Research Funding - AADi (Inst); Lilly (Inst)

Vinod  Ravi

Stock and Other Ownership Interests  - AstraZeneca; Merck; Moderna Therapeutics; Pfizer; TRACON Pharma

Consulting or Advisory Role - Daiichi Sankyo

Research Funding - AADi (Inst); Athenex (Inst); Novartis (Inst); TRACON Pharma (Inst)

Patents, Royalties, Other Intellectual Property - Author Royalties from Uptodate

Travel, Accommodations, Expenses - Daiichi Sankyo

Kristen N.  Ganjoo

Consulting or Advisory Role - Daiichi Sankyo; Deciphera; Foundation Medicine

Gopa  Iyer

Consulting or Advisory Role - Basilea; Bayer; Janssen; Mirati Therapeutics

Research Funding - Bayer (Inst); Debiopharm Group (Inst); Mirati Therapeutics (Inst); Novartis (Inst)